Laurus Labs Ltd - Knowledge, Innovation, Excellence

Corporate Office : 2nd Floor, Serene Chambers, Road No 7, Banjarahills, Hyderabad - 500 034, Telangana, India

Tel: +91 40 3980 4333

Tel: +91 40 6659 4333

Fax: +91 40 3980 4320

Website : www.lauruslabs.com

Registered Office : Laurus Enclave, Plot Office 01, E. Bonangi (V), Parawada (M), Anakapalli (D) - 531 021, AP, India

R & D Center : Plot No: DS1, IKP Knowledge Park, Genome Valley, Turkapally, Medchal–Malkajgiri district , Telangana, India, Pin 500 101

Tel: +91 40 3041 3333

Tel: +91 40 6643 3333

Fax: +91 40 2348 0481

Laurus Generic-API

Unit 1 

Plot No:21, JN Pharma City, Parawada, Visakhapatnam 531021, AP, India.

Tel: +91 891 306 1222

Tel: +91 891 660 1222

Fax: +91 891 3061270

Unit 3 

Plot No:18, JN Pharma City, Parawada, Visakhapatnam 531021, AP, India.

Tel: +91 891 307 2500

Tel: +91 891 668 2500

Fax: +91 891 307 2501

Unit 4

Plot No 25, Lalamkoduru, Atchutapuram, Visakhapatnam 531011, AP, India.

Unit 5

Plot No: 102 & 103, SEZ, Lemarthi, Parwada, Visakhapatnam 531021, AP, India.

Unit 6

Plot No:22D & 22E, APSEZ De-Notified Area,Atchutapuram, Visakhapatnam 531011, AP, India. 

Tel: +91 891 307 2350

Fax: +91 891-3072102

Laurus Synthesis Private Limited

Registered Office : 2nd Floor, Serene Chambers, Road No. 7, Banjara Hills, Hyderabad – 500 034, Telangana, India

Manufacturing Site : Plot No.74 B, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam- 531021, Andhra Pradesh, India

Laurus UK

Laurus Labs Limited

Southgate Chambers, 37/39, Southgate Street, Winchester, Hants SO23 9EH, UK

Laurus Holdings Limited

32, City Business Centre, Hyde, Street Winchester SO23 7TA

As a leading research-driven pharmaceutical and biotechnology company, Laurus Labs aims to improve the quality of life for millions around the world

We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Continuous innovation is the lifeblood of our business. Therefore, undertake dedicated R&D in areas that have significant growth potential. We filed 322 patents in which we own 203 patents. We have commercialised 60+ products since inception across three distinct business units: Generics API, Generics FDF and Synthesis.

As a company, we conduct our business with utmost transparency and integrity. This helps us attract the best talent and win the trust of our stakeholders. Given that we operate in a highly regulated sector, we adopt a high-watermark approach to compliance to ensure that we exceed the requirements of all applicable international standards.